Multiply the umbilical cord cells to improve the success of transplantation
Tuesday, August 17th, 2010New research published in the journal Nature Medicine ‘has proved possible to multiply in the lab, before injecting, so that the transplant will work.
As in the traditional bone marrow transplant, stem cells from a compatible donor umbilical cord are used to regenerate the bone marrow of patients with leukemia and other haematological malignancies. First, chemotherapy ‘clean’ all malignant cells and, subsequently, the umbilical blood of the donor is responsible for ‘repopulate’ again.
The problem is that when stem cells are injected are not enough, take too long to generate new blood cells (clean of cancer). This leaves the patient several weeks with a bone marrow ‘medium gas’ (aplastic), and susceptible to infection, rejection or even death. (more…)
A study published in the medical journal Gut by a group of scientists Netherlands, reveals that
Explains I-Hsin Lin, head of the study, “
The data are published in the online edition of the Journal of the National Cancer Institute. ” However, these biomarkers become greatly elevated only in the year prior to diagnosis. Researchers do not know yet what stage
It was known that
He is known by the unattractive acronym XMRV, which correspond to the no 
